Literature DB >> 19130621

Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord.

Yulin Wang1, Wei Xu, Peng Huang, Charles Chavkin, Elisabeth J Van Bockstaele, Lee-Yuan Liu-Chen.   

Abstract

We investigated whether acute treatment with agonists affected the subcellular distribution of kappa opioid receptor (KOPR) in the dorsal horn of the rat lumbar spinal cord by using immunoelectron microscopy. Rats were injected intrathecally (i.t.) with U50,488H (100 nmole), dynorphin A(1-17) (15 nmole), or vehicle. The doses chosen have been shown to induce antinociception. Rats were perfused transcardially 30 min later, and lumbar spinal cords were removed and processed for electron microscopic analysis. KOPR was stained with KT-2, a specific polyclonal antibody against the rat/mouse KOPR(371-380) peptide, followed by gold-labeled secondary antibody and silver intensification. The silver grains were present in axons, terminals, dendrites, and somata, and the association with plasma membranes was quantified in dendrites, because KOPR immunoreactivity was most frequently observed in these profiles. In vehicle-treated rats, approximately 27% of KOPR immunoreactivity was associated with plasma membranes. U50,488H, i.t., did not cause a significant change in the percentage of KOPR present on plasma membranes, whereas dynorphin A, i.t., significantly decreased cell surface KOPR to approximately 19%. In summary, these data indicate that U50,488H and dynorphin A differentially regulate the subcellular distribution of endogenous KOPR. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130621      PMCID: PMC3489931          DOI: 10.1002/jnr.21971

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  37 in total

1.  Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis.

Authors:  T Stroh; A C Jackson; P Sarret; C Dal Farra; J P Vincent; H J Kreienkamp; J Mazella; A Beaudet
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

2.  Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization.

Authors:  C M Cahill; K A McClellan; A Morinville; C Hoffert; D Hubatsch; D O'Donnell; A Beaudet
Journal:  J Comp Neurol       Date:  2001-11-05       Impact factor: 3.215

3.  Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception.

Authors:  Raf Jan-Filip Schepers; Janet Lynn Mahoney; Toni Shaun Shippenberg
Journal:  Pain       Date:  2007-08-30       Impact factor: 6.961

4.  Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.

Authors:  Jin Li; Jian-Guo Li; Chongguang Chen; Fengqin Zhang; Lee-Yuan Liu-Chen
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

5.  Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

Authors:  H Wang; V M Pickel
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus.

Authors:  E J Van Bockstaele; K G Commons
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

7.  Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.

Authors:  C M Cahill; A Morinville; M C Lee; J P Vincent; B Collier; A Beaudet
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  Kappa opioid receptor density is consistent along the rostrocaudal axis of the female rat spinal cord.

Authors:  J A Harris; C T Drake
Journal:  Brain Res       Date:  2001-06-29       Impact factor: 3.252

9.  Visualizing preference of G protein-coupled receptor kinase 3 for the process of kappa-opioid receptor sequestration.

Authors:  Rüdiger Schulz; Andrea Wehmeyer; Karin Schulz
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

10.  (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.

Authors:  Fengqin Zhang; Jin Li; Jian-Guo Li; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  9 in total

1.  Opiate agonist-induced re-distribution of Wntless, a mu-opioid receptor interacting protein, in rat striatal neurons.

Authors:  B A S Reyes; K Vakharia; T N Ferraro; R Levenson; W H Berrettini; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

2.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

3.  Agonist-induced internalization of κ-opioid receptors in noradrenergic neurons of the rat locus coeruleus.

Authors:  B A S Reyes; Charles Chavkin; E J Van Bockstaele
Journal:  J Chem Neuroanat       Date:  2010-09-25       Impact factor: 3.052

4.  Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Authors:  Yu-Jun Wang; Khampaseuth Rasakham; Peng Huang; Darina Chudnovskaya; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-12       Impact factor: 4.030

5.  Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain.

Authors:  Roland G W Staal; Adarsh Gandhi; Hua Zhou; Manuel Cajina; Anne-Marie Jacobsen; Sara Hestehave; Allen Hopper; Suresh Poda; Gamini Chandresana; Stevin H Zorn; Brian Campbell; Marta Segerdahl; Thomas Mӧller; Gordon Munro
Journal:  Purinergic Signal       Date:  2022-08-24       Impact factor: 3.950

Review 6.  The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

Authors:  E J Van Bockstaele; B A S Reyes; R J Valentino
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

7.  Kappa opioid receptor binding in major depression: A pilot study.

Authors:  Jeffrey M Miller; Francesca Zanderigo; Priya D Purushothaman; Christine DeLorenzo; Harry Rubin-Falcone; R Todd Ogden; John Keilp; Maria A Oquendo; Nabeel Nabulsi; Yiyun H Huang; Ramin V Parsey; Richard E Carson; J John Mann
Journal:  Synapse       Date:  2018-07-17       Impact factor: 2.562

Review 8.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy.

Authors:  Ruth Ruscheweyh; Oliver Wilder-Smith; Ruth Drdla; Xian-Guo Liu; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2011-03-28       Impact factor: 3.395

9.  Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.

Authors:  Antony D Abraham; Sanne M Casello; Benjamin B Land; Charles Chavkin
Journal:  Addict Neurosci       Date:  2022-01-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.